$2.31 Billion is the total value of Carlyle Group Inc.'s 26 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 19.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Quidelortho Corp | $910,091,766 | -11.9% | 12,460,183 | 0.0% | 39.47% | +7.3% | ||
| ZI | Sell | ZoomInfo Technologies Inc | $596,587,606 | -35.9% | 36,377,293 | -0.8% | 25.88% | -22.0% |
| MKSI | MKS Instrs Inc | $301,395,628 | -19.9% | 3,482,732 | 0.0% | 13.07% | -2.5% | |
| VTRU | Vitru Ltd | $109,875,425 | +9.7% | 6,246,471 | 0.0% | 4.77% | +33.6% | |
| Buy | Soleno Therapeutics Inc | $67,430,723 | +1223.6% | 2,293,562 | +90.9% | 2.92% | +1516.0% | |
| Sell | Getty Images Holdings Inc | $63,097,377 | +29.6% | 9,722,246 | -2.5% | 2.74% | +57.8% | |
| GDS | GDS Hldgs Ltdsponsored ads | $44,595,237 | -0.4% | 4,072,624 | 0.0% | 1.93% | +21.3% | |
| VRNA | Verona Pharma Plcsponsored ads | $40,008,100 | -22.9% | 2,457,500 | 0.0% | 1.74% | -6.1% | |
| PHAT | Phathom Pharmaceuticals Inc | $36,191,963 | -27.7% | 3,496,808 | 0.0% | 1.57% | -12.0% | |
| Hillevax Inc | $24,690,867 | -21.7% | 1,838,486 | 0.0% | 1.07% | -4.6% | ||
| RPHM | Reneo Pharmaceuticals Inc | $20,539,063 | +16.2% | 2,698,957 | 0.0% | 0.89% | +41.4% | |
| VERA | Sell | Vera Therapeutics Inccl a | $19,688,342 | -49.2% | 1,438,155 | -40.5% | 0.85% | -38.2% |
| SMHI | Seacor Marine Hldgs Inc | $18,240,596 | +21.4% | 1,314,164 | 0.0% | 0.79% | +47.9% | |
| INVH | Invitation Homes Inc | $15,131,975 | -7.9% | 477,500 | 0.0% | 0.66% | +12.1% | |
| CUBE | CubeSmart | $8,407,665 | -14.6% | 220,500 | 0.0% | 0.36% | +4.0% | |
| SPRB | Spruce Biosciences Inc | $6,459,235 | +3.7% | 2,896,518 | 0.0% | 0.28% | +26.1% | |
| Jasper Therapeutics Inc | $6,054,467 | -48.8% | 8,761,891 | 0.0% | 0.26% | -37.5% | ||
| New | Complete Solaria Inc. | $5,141,511 | – | 2,495,879 | +100.0% | 0.22% | – | |
| EM | Smart Sh Global Ltdads | $3,634,594 | -22.5% | 4,810,209 | 0.0% | 0.16% | -5.4% | |
| ACET | Adicet Bio Inc | $2,876,924 | -43.8% | 2,115,385 | 0.0% | 0.12% | -31.3% | |
| Effector Therapeutics Inc | $2,868,676 | -27.5% | 4,822,114 | 0.0% | 0.12% | -12.1% | ||
| NCNA | Nucana Plcsponsored adr | $1,966,666 | -24.4% | 3,333,333 | 0.0% | 0.08% | -8.6% | |
| Meta Data Limitedsponsored ads | $325,656 | -3.2% | 314,400 | 0.0% | 0.01% | +16.7% | ||
| Exicure Inc | $199,962 | -45.8% | 281,636 | 0.0% | 0.01% | -30.8% | ||
| New | Molecular Templates Inc | $84,265 | – | 13,333 | +100.0% | 0.00% | – | |
| MTEM | Exit | Molecular Templates Inc | $0 | – | -200,000 | -100.0% | -0.00% | – |
| AGLE | Exit | Aeglea Biotherapeutics Inc | $0 | – | -240,500 | -100.0% | -0.00% | – |
| PRTK | Exit | Paratek Pharmaceuticals Inc | $0 | – | -1,041,131 | -100.0% | -0.08% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-03
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Wesco Aircraft Hldgs Inc | 28 | Q4 2019 | 16.8% |
| Seacor Marine Hldgs Inc | 22 | Q3 2023 | 1.1% |
| Enviva Partners LP | 21 | Q2 2020 | 31.5% |
| Enduro Rty Tr | 21 | Q1 2018 | 2.8% |
| USA Compression Partners LP | 20 | Q2 2018 | 28.5% |
| Pattern Energy Group Inc | 20 | Q3 2018 | 16.2% |
| Concord Med Svcs Hldgs Ltd | 19 | Q3 2017 | 1.1% |
| Superior Energy Svcs Inc | 19 | Q3 2017 | 0.7% |
| Cobalt Intl Energy Inc | 17 | Q1 2017 | 11.0% |
| Sequential Brnds Group Inc N | 17 | Q1 2020 | 1.7% |
View Carlyle Group Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Complete Solaria, Inc. | September 22, 2023 | 2,745,879 | 5.7% |
| Carlyle Credit Income Fund | September 14, 2023 | 4,785,628 | 41.0% |
| eFFECTOR Therapeutics, Inc. | August 18, 2023 | 4,829,891 | 7.8% |
| Vera Therapeutics, Inc. | August 02, 2023 | 1,872,764 | 4.2% |
| Reneo Pharmaceuticals, Inc. | May 09, 2023 | 2,730,457 | 8.2% |
| EXICURE, INC. | April 13, 2023 | 287,137 | 3.4% |
| SPRUCE BIOSCIENCES, INC. | February 23, 2023 | 3,734,518 | 9.2% |
| Vaxcyte, Inc. | February 10, 2023 | 2,070,724 | 2.6% |
| NuCana plc | August 11, 2022 | 3,353,134 | 6.4% |
| QuidelOrtho Corp | June 06, 2022 | 12,460,183 | 18.6% |
View Carlyle Group Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| ARS | 2024-04-18 |
| DEF 14A | 2024-04-18 |
| DEFA14A | 2024-04-18 |
| 8-K | 2024-04-03 |
| PRE 14A | 2024-04-03 |
| 4 | 2024-04-02 |
| SC 13G | 2024-03-29 |
| 8-K | 2024-03-27 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Carlyle Group Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.